Skip to main content

Table 2 Difference between acute anti-seizure medication in the group treated with valproic acid and the group treated with levetiracetam matched by gender and main convulsion type variables

From: Etiology of neonatal seizures and maintenance therapy use: a 10-year retrospective study at Toulouse Children’s hospital

 

Valproic acid

Levetiracetam

 
 

N

n

%

N

n

%

p-value

Etiology

17

  

17

   

 Ischemic infarction

 

3

17.65

 

7

41.18

 

 HIE 2

 

2

11.76

 

0

0.00

 

 HIE 3

 

0

0.00

 

1

5.88

 

 Intracranial hemorrhage

 

4

23.53

 

2

11.76

 

 Intracranial infection

 

3

17.65

 

0

0.00

 

 Cerebral malformation

 

0

0.00

 

1

5.88

 

 Metabolic disorder

 

1

5.88

 

0

0.00

 

 Inborn error of metabolism

 

0

0.00

 

1

5.88

 

 Benign epileptic syndromes

 

3

17.65

 

3

17.65

 

 Severe epileptic syndromes

 

1

5.88

 

1

5.88

 

 Unknown

 

0

0.00

 

1

5.88

 

Number of emergency drugs

17

  

16

  

0.012

 0

 

1

5.88

 

1

6.25

 

 1

 

1

5.88

 

8

50.00

 

 2

 

7

41.18

 

6

37.50

 

 3

 

8

47.06

 

1

6.25

 

First-line emergency drug

17

  

16

  

0.097

 0

 

1

5.88

 

1

6.25

 

 diazepam

 

9

52.94

 

3

18.75

 

 phenobarbital

 

5

29.41

 

12

75.00

 

 phenytoin

 

1

5.88

    

 clonazepam

 

1

5.88

    

Second-line emergency drug

15

  

7

  

0.700

 diazepam

 

1

6.67

    

 phenobarbital

 

9

60.00

 

3

42.86

 

 phenytoin

 

4

26.67

 

3

42.86

 

 clonazepam

 

1

6.67

 

1

14.29

 

Third-line emergency drug

8

  

1

  

0.708

 phenytoin

 

7

87.50

 

1

100.00

 

 clonazepam

 

1

12,50

    
  1. HIE hypoxic-ischemic encephalopathy